BRTE yields 2000000.00% · PFE yields 6.20%● Live data
📍 BRTE pulled ahead of the other in Year 1
Combined, BRTE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRTE + PFE for your $10,000?
Brightec, Inc. engages in the development and marketing of luminescent films incorporating luminescent or phosphorescent pigments in the United States. These pigments absorb and re-emit visible light producing a glow. The company markets and sells films and consumer products, which incorporate luminescent or phosphorescent pigments and are based on its proprietary and patented technology that enables prints to be of photographic quality by day and luminescent under low light or night conditions. It offers various types of glow-in-the-dark films in sheets and rolls for commercial and digital printing needs of the graphic industry, and office and photographic digital printing market; and consumer products, including children puzzles and children stickers under the brand name PlayGlo. The company sells its luminescent product primarily as a printable luminescent film designed to add luminescence to existing and new products. It offers its product through its online store. The company was formerly known as Advanced Lumitech, Inc. and changed its name to Brightec, Inc. in October 2006. Brightec, Inc. was founded in 1992 and is based in Natick, Massachusetts.
Full BRTE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.